Skip to main content
Clinical Trials/ISRCTN37153662
ISRCTN37153662
Completed
未知

Comparison between continuous subcutaneous insulin infusion with multiple basal lispro infusion rates and multiple daily insulin injection with lispro and glargine

Disetronic Medical Systems AG (Switzerland)0 sites50 target enrollmentApril 25, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetes mellitus type one
Sponsor
Disetronic Medical Systems AG (Switzerland)
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2008 Results article in https://doi.org/10.1111/j.1464-5491.2007.02365.x (added 22/09/2021)

Registry
who.int
Start Date
April 25, 2007
End Date
May 16, 2005
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Disetronic Medical Systems AG (Switzerland)

Eligibility Criteria

Inclusion Criteria

  • 1\. Type one diabetic patients (World Health Organisation \[WHO] classification)
  • 2\. Between 18 and 60 years old
  • 3\. Have been diabetics for more than two years
  • 4\. Have been treated with CSII for at least six months prior to the study
  • 5\. HbA1c needs to be less than 8\.5%
  • 6\. Patients should be familiar with carbohydrate counting and should be able to change insulin doses (either by pump or injections) based on changes in food intake and physical exercise

Exclusion Criteria

  • 1\. Poor motivation
  • 2\. Body Mass Index (BMI) greater than 30 kg/m^2
  • 3\. Treatment with daily insulin injections
  • 4\. Inability to handle pump therapy (pump handling, infusion set handling, compliance with treatment rules)
  • 5\. Untreated retinopathy

Outcomes

Primary Outcomes

Not specified

Similar Trials